Literature DB >> 33091504

Expression of protein kinase HIPK2 is subject to a quality control mechanism that acts during translation and requires its kinase activity to prevent degradation of nascent HIPK2.

Jan Paul Müller1, Stephan Scholl2, Conrad Kunick3, Karl-Heinz Klempnauer4.   

Abstract

HIPK2 is a highly conserved, constitutively active Ser/Thr protein kinase that is involved in a broad spectrum of biological processes. We have previously reported that the expression of HIPK2 is auto-regulated by a mechanism that depends on the activity of its kinase domain, leading to decreased expression of kinase-dead versus wild-type HIPK2. We have now explored this mechanism in more detail. Differential expression of wild-type and kinase-dead HIPK2 is dependent on sequences located in the C-terminal part of HIPK2, but is only observed when this part of HIPK2 is translated together with the defective kinase domain. On their own, both the defective kinase domain and the C-terminal amino acid sequences are expressed at normal levels and independently of kinase activity. Insertion of a 2A-ribosomal skipping sequence into the HIPK2 coding sequence revealed that the differential expression of wild-type and kinase-dead HIPK2 is caused by degradation of nascent kinase-dead HIPK2. Because HIPK2 is constitutively active and auto-activates its kinase domain already during its translation we speculate that the regulatory mechanism discovered here serves as a quality control mechanism that leads to degradation of nascent kinase molecules with defective kinase domains. Overall our work provides insight into a novel auto-regulatory mechanism of HIPK2 expression, thereby adding a new layer of control to the regulation of HIPK2.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Auto-phosphorylation; Auto-regulation; HIPK2; Kinase domain; Translation

Mesh:

Substances:

Year:  2020        PMID: 33091504     DOI: 10.1016/j.bbamcr.2020.118894

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  1 in total

1.  Assessment of Sacsin Turnover in Patients With ARSACS: Implications for Molecular Diagnosis and Pathogenesis.

Authors:  Fabiana Longo; Daniele De Ritis; Annarita Miluzio; Davide Fraticelli; Jonathan Baets; Marina Scarlato; Filippo M Santorelli; Stefano Biffo; Francesca Maltecca
Journal:  Neurology       Date:  2021-10-14       Impact factor: 9.910

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.